~Revolutionizing Genomics for Personalized Cancer Care~
Bangalore, May 26, 2017: Envisioned to define the future of cancer care in India,Healthcare Global Enterprises Ltd. –The Specialist in Cancer Care today inaugurated the Triesta Genomics and Translational Research Center. It is a state-of-the-art Genomics Center offering comprehensive diagnosis by leveraging the latest and innovative technologies like Next-Generation Sequencing to all patients.
Triesta Genomics and Translational Research Center will support an emerging medical discipline called Genomic Medicine that involves usage of genomic data of patients for better diagnosis. These will help in making therapeutic decisions more effective and help improve health outcomes for patients.
With the largest patient base in private cancer care, HCG – Triesta Genomics and Translational Research Center stands on a strong foundation based on their access to the availability of well-annotated tissue biorepository, clinical data along with a strong clinical excellence of oncologists and scientists. The aim is to aid oncologists in their relentless pursuit to deliver personalized medicine using the genetic data of patients for better diagnosis at the very first time and achieve overall improved health outcomes.
Also present at the conference,Dr. Mithua Ghosh, Director and Head- of Triesta Genomics and Translational Research Center said, “Understanding the genetic signature or profile of the cancer helps oncologists penetrate the root level cause of the disease at the molecular and genetic level.The application of next-generation advanced technologies has set its foot strongly in diagnostics and understanding the molecular landscape of cancer, which, in turn, has facilitated the development of diagnostic, prognostic and predictive biomarkers for clinical oncology. With HCG’s Genetic Counselling center and preventive oncology clinic, we have expanded the collaborative role in patient care to support the patients and their family members.Along with this, and the constant addition of new technologies like Liquid Biopsy, our center is also well-equipped to cater to the research and development needs of Biotech, Pharma, and the CRO sector.”
The center has also partnered with Strand Life Sciences for clinical informatics. The wealth of data emerging from cancer genome studies will be integrated with patients’ medical histories and clinical data using predictive and big data analytics. This “Genomics Data Bank” can lead to a better understanding of Indian population genetics and help develop more tailored approaches to predict treatment response in patients.
Dr.Intezar Mehdi – Consultant – Pediatric Oncology, Hematology and BMT and Dr. Vijay Agarwal – Consultant – Medical Oncology said, “Having a molecular along with a clinical genomics laboratory and the right expertise adds up to a lot of value. There is a seamless interaction between the clinicians, molecular pathologists, geneticists, which enables us not only to adopt the comprehensive multidisciplinary diagnostic approach to treat cancer, but it also gives us an opportunity to answer our research by accessing the latest and innovative technologies.”
With this launch, HCG has revolutionized cancer treatment, making it accessible for all patients to focus on improved outcomes.
Corporate Comm India (CCI Newswire)
New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…